-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Enanta Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2011 to 2023.
- Enanta Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 21.2M shares, a 0.6% increase year-over-year.
- Enanta Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 21M shares, a 1.78% increase from 2022.
- Enanta Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 20.6M shares, a 2.14% increase from 2021.
- Enanta Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 20.2M shares, a 1.16% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)